1. The rules governing medicinal products in the European Union (Eudralex), Vol. 4 – Good manufacturing practice. European Commission Enterprise DG-Pharmaceuticals.
2. European Pharmacopoeia, 4th Edition, 2002. General notices.
3. European Pharmacopoeia, 4th Edition, 2002, Sect. 2.2.40. Near-infrared spectrophotometry.
4. Note for Guidance on the use of near infrared spectroscopy by the pharmaceutical industry and the data to be forwarded in part II of the dossier for a marketing authorisation. EMEA/CVMP/961/01-CPMP/QWP/3309/01 draft – released for consultation 14 November 2001. The European Agency for the Evaluation of Medicinal Products, London.
5. Note for Guidance on the use of near infrared spectroscopy by the pharmaceutical industry and the data to be forwarded in part II of the dossier for a marketing authorisation. CPMP/QWP/3309/01 – adopted by CPMP/CVMP February 2003. The European Agency for the Evaluation of Medicinal Products, London.